Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 40

Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 121
Private Equity Firm Frazier Healthcare Partners Picks Up RevSpring

Private Equity Firm Frazier Healthcare Partners Picks Up RevSpring

Healthcare-focused private equity firm Frazier Healthcare Partners announced on March 12 the completion of its acquisition of RevSpring from Chicago, Illinois-based GTCR. Frazier is joined in the transaction by NEA, 22C Capital and RevSpring’s senior leadership team.  RevSpring offers physical and electronic invoices, consumer payment portals, data cleansing solutions and analytics tools. It serves a client base of approximately 2,000 health systems and hospitals, revenue cycle management (RCM) providers and financial services organizations. The company was originally acquired by GTCR in November 2016.  Frazier Healthcare Partners is a provider of growth capital to healthcare... Read More »
Fortrea Divests Assets to Arsenal Capital Partners for $345 Million 

Fortrea Divests Assets to Arsenal Capital Partners for $345 Million 

Fortrea, a Durham, North Carolina-based global contract research organization (CRO), is divesting certain assets to Arsenal Capital Partners for $345 million.   The assets being divested relate to Fortrea’s Enabling Services segment, including the businesses Endpoint Clinical and Fortrea Patient Access. In 2023, Fortrea generated revenues of about $3.11 billion compared to about $3.1 billion the previous year, according to the original press release.  Arsenal is a New York, New York-based private equity firm that specializes in investments in healthcare and industrial growth companies. Since its inception in 2000, Arsenal has raised institutional equity investment funds of more... Read More »
A Look at the Managed Care Public Market of 2023 

A Look at the Managed Care Public Market of 2023 

The Managed Care sector witnessed a dynamic year in 2023, with key players navigating various challenges and opportunities. This analysis explores the financial trajectories of major companies, including Humana, Cigna, UnitedHealth Group, Elevance Health, Centene and Molina, shedding light on the trends, challenges and strategies currently shaping the market. Market Overview: Over the years, Managed Care companies have demonstrated resilience and growth. The market has consistently followed an upward trajectory, with most of the major players experiencing revenue growth each year. Source: Macrotrends UnitedHealth Group stands out as the revenue leader, with consistently strong revenue... Read More »
Carenet Health Acquires Assets of Health Dialog from Rite Aid

Carenet Health Acquires Assets of Health Dialog from Rite Aid

Carenet Health announced that it is acquiring Health Dialog, a wholly owned subsidiary of Rite Aid Corporation. This acquisition enables Carenet to leverage its combined platform, analytics and clinicians to deliver greater efficiency and outcomes-based financial performance for clients.  Health Dialog is a leading provider of population health management solutions. The company works with the U.S.’s largest health plans, employers and providers to improve the health and wellness of their members, employees, patients and customers. Health Dialog’s capabilities include data analytics, a multi-channel coaching platform, shared decision-making tools and a 24/7 nurse... Read More »
Halma Expands Health Tech Portfolio With a More Than $90 Million Acquisition

Halma Expands Health Tech Portfolio With a More Than $90 Million Acquisition

Halma plc has announced the acquisition of Rovers Medical Devices BV, marking a significant step in expanding its healthcare technology offerings and driving innovation. The company is being acquired for an initial cash consideration of €85 million (approximately $91.8 million USD), with additional payments of up to €6 million (about $6.5 million) pending future performance. Rovers Medical Devices BV is involved in the development, production and world-wide sales of medical devices with a focus on cell sampling devices. The company had a revenue of €12 million (about $13 million USD) for the 12 months ending December 31, 2023, according to the original deal press release. Halma is a global... Read More »
Summit BHC Enters New England Market With Sobriety Centers of New Hampshire Acquisition

Summit BHC Enters New England Market With Sobriety Centers of New Hampshire Acquisition

Summit BHC has announced its entry into the New England market with the acquisition of Sobriety Centers of New Hampshire (SCNH). Financial terms of the deal were not disclosed. SCNH operates addiction treatment facilities in New Hampshire. These centers provide a broad array of substance use disorder treatments and services, including detoxification, residential and various levels of outpatient programs. Summit BHC was founded in 2013 to develop and operate a network of leading addiction treatment and behavioral health centers throughout the United States. Including the newly acquired facilities, the company owns and operates 31 inpatient facilities across 19 states. Its services include... Read More »
First Fertility Acquires Fertility Specialists of Texas

First Fertility Acquires Fertility Specialists of Texas

First Fertility announced on March 5 that it entered into an agreement to expand its network in Texas by acquiring Fertility Specialists of Texas. Fertility Specialists of Texas is a nationally renowned fertility and IVF practice with six locations throughout the Dallas-Fort Worth and Lubbock, Texas MSA. According to its website, it has six providers on staff. First Fertility is one of the largest fertility networks in the United States. It has 37 locations in North America, serving patients in 13 states, including Alabama, Connecticut, Florida, Illinois, Louisiana, Maine, Massachusetts, Mississippi, Missouri, New Hampshire, New York, Oklahoma, Rhode Island and Texas. This partnership... Read More »
Haemonetics to Acquire Medical Device Company Attune Medical

Haemonetics to Acquire Medical Device Company Attune Medical

Haemonetics Corporation announced on March 5 that it has entered into a definitive agreement to acquire privately-held Chicago-based Attune Medical. Under the terms of the agreement, Haemonetics will acquire Attune Medical for an upfront cash payment of $160 million at closing plus additional contingent consideration based on sales growth in the three years following the consummation of the transaction and the achievement of other milestones. Attune Medical is a provider of a medical device, the ensoETM® proactive esophageal cooling device, used to control the core temperature of the patient’s body. ensoETM is the only FDA-cleared temperature regulation device indicated for... Read More »
PE Firm WindRose Health Investors Acquires CardioOne

PE Firm WindRose Health Investors Acquires CardioOne

Private equity firm WindRose Health Investors, LLC announced that it has completed the acquisition of CardioOne Inc. WindRose partnered with CardioOne’s executive team to acquire the business and to provide up to $100 million of additional capital to support CardioOne’s ongoing growth. Launched in 2023, CardioOne is a physician enablement company that enables independent cardiology practices to unlock their potential. The company is a management services partner that provides physicians with an integrated technology platform, a practice optimization program, a workforce solution and a growth engine. WindRose Health Investors, formerly MTS Health Investors, makes private equity... Read More »
Why Invest in the ENT Market

Why Invest in the ENT Market

The ear, nose and throat (ENT) market, also known as otolaryngology, encompasses a wide range of services. For our purposes, we categorize all ENT and allergy-related services under the ENT subsector. This classification is based on the comprehensive expertise of otolaryngologists, who are trained in both medical and surgical treatments pertaining to the head and its associated areas. The ENT market has experienced an influx of deal activity over the last few years. According to data captured in the LevinPro HC database, there were eight acquisitions in 2018, and four were reported in 2019. Deal volume hit a low in 2020 with two transactions. M&A activity then sprung back in 2021 with... Read More »